ºÝºÝߣ

Malibu, CA United States

Physician/Scientist

Medical / Health Care / Pharmaceuticals

Between Nov. 2008 and Dec. 2009, Winson Tang MD worked as a Medical Consultant for Amsterdam Molecular Therapeutics in Amsterdam, The Netherlands. He was responsible for the conduct of Phase 2/3 Glybera orphan drug registration trial for lipoprotein lipase deficiency. He was also instrumental in the development of the Glybera product profile. The MAA for Glybera was submitted to the EMA in Dec 2009. It is the first and remains the only gene therapy product approved in the western world.